nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—acquired immunodeficiency syndrome	0.242	1	CbGaD
Norethindrone—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0239	0.0392	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0239	0.0392	CbGbCtD
Norethindrone—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0206	0.0339	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0206	0.0339	CbGbCtD
Norethindrone—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.02	0.0329	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.02	0.0329	CbGbCtD
Norethindrone—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0198	0.0325	CbGbCtD
Norethindrone—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0181	0.0297	CbGbCtD
Norethindrone—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0181	0.0297	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0181	0.0297	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0181	0.0297	CbGbCtD
Norethindrone—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0179	0.0294	CbGbCtD
Norethindrone—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0179	0.0294	CbGbCtD
Norethindrone—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.017	0.0279	CbGbCtD
Norethindrone—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0169	0.0277	CbGbCtD
Norethindrone—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0162	0.0266	CbGbCtD
Norethindrone—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.016	0.0262	CbGbCtD
Norethindrone—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0154	0.0254	CbGbCtD
Norethindrone—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.015	0.0247	CbGbCtD
Norethindrone—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0144	0.0237	CbGbCtD
Norethindrone—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0144	0.0237	CbGbCtD
Norethindrone—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0136	0.0223	CbGbCtD
Norethindrone—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0136	0.0223	CbGbCtD
Norethindrone—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0129	0.0212	CbGbCtD
Norethindrone—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0125	0.0205	CbGbCtD
Norethindrone—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0121	0.0199	CbGbCtD
Norethindrone—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0116	0.0191	CbGbCtD
Norethindrone—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0109	0.018	CbGbCtD
Norethindrone—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0109	0.018	CbGbCtD
Norethindrone—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0105	0.0172	CbGbCtD
Norethindrone—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0101	0.0165	CbGbCtD
Norethindrone—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00976	0.016	CbGbCtD
Norethindrone—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00883	0.0145	CbGbCtD
Norethindrone—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00883	0.0145	CbGbCtD
Norethindrone—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00846	0.0139	CbGbCtD
Norethindrone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00821	0.0135	CbGbCtD
Norethindrone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00772	0.0127	CbGbCtD
Norethindrone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00772	0.0127	CbGbCtD
Norethindrone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00698	0.0115	CbGbCtD
Norethindrone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00698	0.0115	CbGbCtD
Norethindrone—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00655	0.0108	CbGbCtD
Norethindrone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00602	0.0099	CbGbCtD
Norethindrone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00585	0.00961	CbGbCtD
Norethindrone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00529	0.00869	CbGbCtD
Norethindrone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00529	0.00869	CbGbCtD
Norethindrone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00507	0.00834	CbGbCtD
Norethindrone—SHBG—semen—acquired immunodeficiency syndrome	0.00417	0.213	CbGeAlD
Norethindrone—SHBG—blood plasma—acquired immunodeficiency syndrome	0.00152	0.0776	CbGeAlD
Norethindrone—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00101	0.0516	CbGeAlD
Norethindrone—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000796	0.0407	CbGeAlD
Norethindrone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000598	0.0305	CbGeAlD
Norethindrone—SHBG—blood—acquired immunodeficiency syndrome	0.000557	0.0284	CbGeAlD
Norethindrone—SHBG—bone marrow—acquired immunodeficiency syndrome	0.000539	0.0275	CbGeAlD
Norethindrone—PGR—lymphoid tissue—acquired immunodeficiency syndrome	0.000533	0.0272	CbGeAlD
Norethindrone—SHBG—vagina—acquired immunodeficiency syndrome	0.000516	0.0264	CbGeAlD
Norethindrone—PGR—blood—acquired immunodeficiency syndrome	0.000502	0.0256	CbGeAlD
Norethindrone—PGR—vagina—acquired immunodeficiency syndrome	0.000465	0.0238	CbGeAlD
Norethindrone—PGR—lung—acquired immunodeficiency syndrome	0.00044	0.0225	CbGeAlD
Norethindrone—SHBG—central nervous system—acquired immunodeficiency syndrome	0.000435	0.0222	CbGeAlD
Norethindrone—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000423	0.0216	CbGeAlD
Norethindrone—PGR—nervous system—acquired immunodeficiency syndrome	0.000407	0.0208	CbGeAlD
Norethindrone—PGR—central nervous system—acquired immunodeficiency syndrome	0.000392	0.02	CbGeAlD
Norethindrone—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000389	0.0199	CbGeAlD
Norethindrone—CYP2C19—blood—acquired immunodeficiency syndrome	0.00037	0.0189	CbGeAlD
Norethindrone—SHBG—brain—acquired immunodeficiency syndrome	0.000346	0.0177	CbGeAlD
Norethindrone—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000343	0.0175	CbGeAlD
Norethindrone—PGR—brain—acquired immunodeficiency syndrome	0.000311	0.0159	CbGeAlD
Norethindrone—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000306	0.0156	CbGeAlD
Norethindrone—PGR—lymph node—acquired immunodeficiency syndrome	0.000301	0.0154	CbGeAlD
Norethindrone—CYP3A5—blood—acquired immunodeficiency syndrome	0.000292	0.0149	CbGeAlD
Norethindrone—ALB—brain—acquired immunodeficiency syndrome	0.000285	0.0146	CbGeAlD
Norethindrone—ALB—lymph node—acquired immunodeficiency syndrome	0.000276	0.0141	CbGeAlD
Norethindrone—CYP3A5—vagina—acquired immunodeficiency syndrome	0.00027	0.0138	CbGeAlD
Norethindrone—CYP3A5—lung—acquired immunodeficiency syndrome	0.000256	0.0131	CbGeAlD
Norethindrone—ABCB1—retina—acquired immunodeficiency syndrome	0.000232	0.0118	CbGeAlD
Norethindrone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00023	0.0117	CbGeAlD
Norethindrone—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.00177	CcSEcCtD
Norethindrone—Tension—Efavirenz—acquired immunodeficiency syndrome	0.000229	0.00176	CcSEcCtD
Norethindrone—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.00176	CcSEcCtD
Norethindrone—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.00176	CcSEcCtD
Norethindrone—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000227	0.00175	CcSEcCtD
Norethindrone—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000227	0.00175	CcSEcCtD
Norethindrone—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.00175	CcSEcCtD
Norethindrone—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000226	0.00174	CcSEcCtD
Norethindrone—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000226	0.00174	CcSEcCtD
Norethindrone—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000226	0.00174	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.00173	CcSEcCtD
Norethindrone—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.00173	CcSEcCtD
Norethindrone—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00173	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000223	0.00172	CcSEcCtD
Norethindrone—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000223	0.00172	CcSEcCtD
Norethindrone—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000223	0.00171	CcSEcCtD
Norethindrone—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000223	0.00171	CcSEcCtD
Norethindrone—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000222	0.00171	CcSEcCtD
Norethindrone—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000222	0.00171	CcSEcCtD
Norethindrone—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.00022	0.0017	CcSEcCtD
Norethindrone—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00169	CcSEcCtD
Norethindrone—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.00022	0.00169	CcSEcCtD
Norethindrone—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000219	0.00169	CcSEcCtD
Norethindrone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000219	0.0112	CbGeAlD
Norethindrone—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.00168	CcSEcCtD
Norethindrone—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.00167	CcSEcCtD
Norethindrone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00167	CcSEcCtD
Norethindrone—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00167	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000216	0.00166	CcSEcCtD
Norethindrone—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.00166	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000215	0.00166	CcSEcCtD
Norethindrone—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000215	0.00166	CcSEcCtD
Norethindrone—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00165	CcSEcCtD
Norethindrone—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.00165	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000212	0.00163	CcSEcCtD
Norethindrone—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000212	0.00163	CcSEcCtD
Norethindrone—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000212	0.00163	CcSEcCtD
Norethindrone—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000211	0.00163	CcSEcCtD
Norethindrone—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.00162	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000209	0.00161	CcSEcCtD
Norethindrone—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.0016	CcSEcCtD
Norethindrone—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00159	CcSEcCtD
Norethindrone—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000206	0.00159	CcSEcCtD
Norethindrone—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00159	CcSEcCtD
Norethindrone—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000205	0.00158	CcSEcCtD
Norethindrone—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000205	0.00157	CcSEcCtD
Norethindrone—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000204	0.00157	CcSEcCtD
Norethindrone—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000204	0.00157	CcSEcCtD
Norethindrone—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.00157	CcSEcCtD
Norethindrone—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000203	0.00156	CcSEcCtD
Norethindrone—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.00156	CcSEcCtD
Norethindrone—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.00156	CcSEcCtD
Norethindrone—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.00155	CcSEcCtD
Norethindrone—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00155	CcSEcCtD
Norethindrone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00155	CcSEcCtD
Norethindrone—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000201	0.00155	CcSEcCtD
Norethindrone—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.00154	CcSEcCtD
Norethindrone—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.0002	0.00154	CcSEcCtD
Norethindrone—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.00154	CcSEcCtD
Norethindrone—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000199	0.00153	CcSEcCtD
Norethindrone—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000199	0.00153	CcSEcCtD
Norethindrone—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000199	0.00153	CcSEcCtD
Norethindrone—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000198	0.00153	CcSEcCtD
Norethindrone—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.00152	CcSEcCtD
Norethindrone—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000198	0.00152	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00152	CcSEcCtD
Norethindrone—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000197	0.00152	CcSEcCtD
Norethindrone—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00151	CcSEcCtD
Norethindrone—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000196	0.00151	CcSEcCtD
Norethindrone—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.00151	CcSEcCtD
Norethindrone—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000196	0.00151	CcSEcCtD
Norethindrone—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000195	0.0015	CcSEcCtD
Norethindrone—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000194	0.0015	CcSEcCtD
Norethindrone—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.00148	CcSEcCtD
Norethindrone—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.00148	CcSEcCtD
Norethindrone—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.00147	CcSEcCtD
Norethindrone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00019	0.00147	CcSEcCtD
Norethindrone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000187	0.00144	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000187	0.00144	CcSEcCtD
Norethindrone—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000187	0.00144	CcSEcCtD
Norethindrone—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00144	CcSEcCtD
Norethindrone—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.00143	CcSEcCtD
Norethindrone—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000185	0.00143	CcSEcCtD
Norethindrone—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.00142	CcSEcCtD
Norethindrone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000184	0.00142	CcSEcCtD
Norethindrone—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00142	CcSEcCtD
Norethindrone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000184	0.00141	CcSEcCtD
Norethindrone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000183	0.00141	CcSEcCtD
Norethindrone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000183	0.00141	CcSEcCtD
Norethindrone—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000182	0.0014	CcSEcCtD
Norethindrone—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.0014	CcSEcCtD
Norethindrone—Rash—Didanosine—acquired immunodeficiency syndrome	0.000181	0.00139	CcSEcCtD
Norethindrone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000181	0.00139	CcSEcCtD
Norethindrone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000181	0.00139	CcSEcCtD
Norethindrone—Headache—Didanosine—acquired immunodeficiency syndrome	0.00018	0.00139	CcSEcCtD
Norethindrone—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00018	0.00138	CcSEcCtD
Norethindrone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000179	0.00138	CcSEcCtD
Norethindrone—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000179	0.00138	CcSEcCtD
Norethindrone—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00138	CcSEcCtD
Norethindrone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000178	0.00908	CbGeAlD
Norethindrone—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000178	0.00137	CcSEcCtD
Norethindrone—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.00136	CcSEcCtD
Norethindrone—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00136	CcSEcCtD
Norethindrone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000177	0.00136	CcSEcCtD
Norethindrone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000177	0.00136	CcSEcCtD
Norethindrone—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000176	0.00136	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00134	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000174	0.00134	CcSEcCtD
Norethindrone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000174	0.00134	CcSEcCtD
Norethindrone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000174	0.00134	CcSEcCtD
Norethindrone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.00133	CcSEcCtD
Norethindrone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.00133	CcSEcCtD
Norethindrone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.00133	CcSEcCtD
Norethindrone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.00132	CcSEcCtD
Norethindrone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000171	0.00874	CbGeAlD
Norethindrone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000171	0.00131	CcSEcCtD
Norethindrone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.0013	CcSEcCtD
Norethindrone—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.0013	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00129	CcSEcCtD
Norethindrone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.00129	CcSEcCtD
Norethindrone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.00127	CcSEcCtD
Norethindrone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000165	0.00127	CcSEcCtD
Norethindrone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000165	0.00127	CcSEcCtD
Norethindrone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00127	CcSEcCtD
Norethindrone—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000165	0.00841	CbGeAlD
Norethindrone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.00127	CcSEcCtD
Norethindrone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.00126	CcSEcCtD
Norethindrone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000164	0.00126	CcSEcCtD
Norethindrone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000164	0.00126	CcSEcCtD
Norethindrone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.00126	CcSEcCtD
Norethindrone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.00125	CcSEcCtD
Norethindrone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.00125	CcSEcCtD
Norethindrone—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000163	0.00831	CbGeAlD
Norethindrone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000163	0.00125	CcSEcCtD
Norethindrone—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.00125	CcSEcCtD
Norethindrone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.00125	CcSEcCtD
Norethindrone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000162	0.00125	CcSEcCtD
Norethindrone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.00124	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.00123	CcSEcCtD
Norethindrone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00016	0.00123	CcSEcCtD
Norethindrone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000159	0.00123	CcSEcCtD
Norethindrone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000159	0.00122	CcSEcCtD
Norethindrone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000159	0.00122	CcSEcCtD
Norethindrone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.00121	CcSEcCtD
Norethindrone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.00121	CcSEcCtD
Norethindrone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.00121	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.00121	CcSEcCtD
Norethindrone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000157	0.00121	CcSEcCtD
Norethindrone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000157	0.00121	CcSEcCtD
Norethindrone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000157	0.00121	CcSEcCtD
Norethindrone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000157	0.00121	CcSEcCtD
Norethindrone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000156	0.0012	CcSEcCtD
Norethindrone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000156	0.0012	CcSEcCtD
Norethindrone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.0012	CcSEcCtD
Norethindrone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000156	0.0012	CcSEcCtD
Norethindrone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000155	0.00119	CcSEcCtD
Norethindrone—ABCB1—blood—acquired immunodeficiency syndrome	0.000155	0.00792	CbGeAlD
Norethindrone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000155	0.00119	CcSEcCtD
Norethindrone—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.00119	CcSEcCtD
Norethindrone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.00119	CcSEcCtD
Norethindrone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000154	0.00118	CcSEcCtD
Norethindrone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000154	0.00118	CcSEcCtD
Norethindrone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.00118	CcSEcCtD
Norethindrone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.00117	CcSEcCtD
Norethindrone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00116	CcSEcCtD
Norethindrone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00116	CcSEcCtD
Norethindrone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00116	CcSEcCtD
Norethindrone—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.00015	0.00766	CbGeAlD
Norethindrone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.00115	CcSEcCtD
Norethindrone—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000149	0.00763	CbGeAlD
Norethindrone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.00115	CcSEcCtD
Norethindrone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000149	0.00114	CcSEcCtD
Norethindrone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000149	0.00114	CcSEcCtD
Norethindrone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.00114	CcSEcCtD
Norethindrone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000148	0.00114	CcSEcCtD
Norethindrone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.00113	CcSEcCtD
Norethindrone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000146	0.00112	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00112	CcSEcCtD
Norethindrone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.00112	CcSEcCtD
Norethindrone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.00111	CcSEcCtD
Norethindrone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000145	0.00111	CcSEcCtD
Norethindrone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00111	CcSEcCtD
Norethindrone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.00111	CcSEcCtD
Norethindrone—ABCB1—vagina—acquired immunodeficiency syndrome	0.000144	0.00734	CbGeAlD
Norethindrone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.0011	CcSEcCtD
Norethindrone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.0011	CcSEcCtD
Norethindrone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000143	0.0011	CcSEcCtD
Norethindrone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.00108	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00108	CcSEcCtD
Norethindrone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00108	CcSEcCtD
Norethindrone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.00108	CcSEcCtD
Norethindrone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.00106	CcSEcCtD
Norethindrone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.00106	CcSEcCtD
Norethindrone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00106	CcSEcCtD
Norethindrone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.00105	CcSEcCtD
Norethindrone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.00105	CcSEcCtD
Norethindrone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.00105	CcSEcCtD
Norethindrone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.00105	CcSEcCtD
Norethindrone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000136	0.00105	CcSEcCtD
Norethindrone—ABCB1—lung—acquired immunodeficiency syndrome	0.000136	0.00694	CbGeAlD
Norethindrone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.00104	CcSEcCtD
Norethindrone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.00103	CcSEcCtD
Norethindrone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.00103	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.00103	CcSEcCtD
Norethindrone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00103	CcSEcCtD
Norethindrone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000133	0.00103	CcSEcCtD
Norethindrone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00103	CcSEcCtD
Norethindrone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.00102	CcSEcCtD
Norethindrone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.00101	CcSEcCtD
Norethindrone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000993	CcSEcCtD
Norethindrone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000992	CcSEcCtD
Norethindrone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000991	CcSEcCtD
Norethindrone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000987	CcSEcCtD
Norethindrone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000987	CcSEcCtD
Norethindrone—Rash—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000979	CcSEcCtD
Norethindrone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000978	CcSEcCtD
Norethindrone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000974	CcSEcCtD
Norethindrone—Headache—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000972	CcSEcCtD
Norethindrone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.00097	CcSEcCtD
Norethindrone—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000126	0.00643	CbGeAlD
Norethindrone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000124	0.000956	CcSEcCtD
Norethindrone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000946	CcSEcCtD
Norethindrone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000942	CcSEcCtD
Norethindrone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000932	CcSEcCtD
Norethindrone—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000121	0.00619	CbGeAlD
Norethindrone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000931	CcSEcCtD
Norethindrone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000928	CcSEcCtD
Norethindrone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000925	CcSEcCtD
Norethindrone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000924	CcSEcCtD
Norethindrone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000922	CcSEcCtD
Norethindrone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.00092	CcSEcCtD
Norethindrone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000919	CcSEcCtD
Norethindrone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000918	CcSEcCtD
Norethindrone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000896	CcSEcCtD
Norethindrone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000892	CcSEcCtD
Norethindrone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000885	CcSEcCtD
Norethindrone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000884	CcSEcCtD
Norethindrone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000884	CcSEcCtD
Norethindrone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000879	CcSEcCtD
Norethindrone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000878	CcSEcCtD
Norethindrone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.000871	CcSEcCtD
Norethindrone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000858	CcSEcCtD
Norethindrone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000855	CcSEcCtD
Norethindrone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000843	CcSEcCtD
Norethindrone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000833	CcSEcCtD
Norethindrone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000826	CcSEcCtD
Norethindrone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000825	CcSEcCtD
Norethindrone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000818	CcSEcCtD
Norethindrone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000817	CcSEcCtD
Norethindrone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000813	CcSEcCtD
Norethindrone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000794	CcSEcCtD
Norethindrone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000788	CcSEcCtD
Norethindrone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000787	CcSEcCtD
Norethindrone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000787	CcSEcCtD
Norethindrone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000782	CcSEcCtD
Norethindrone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000771	CcSEcCtD
Norethindrone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.84e-05	0.000757	CcSEcCtD
Norethindrone—Rash—Lamivudine—acquired immunodeficiency syndrome	9.76e-05	0.000751	CcSEcCtD
Norethindrone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.75e-05	0.00075	CcSEcCtD
Norethindrone—Headache—Lamivudine—acquired immunodeficiency syndrome	9.7e-05	0.000746	CcSEcCtD
Norethindrone—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.64e-05	0.000742	CcSEcCtD
Norethindrone—ABCB1—brain—acquired immunodeficiency syndrome	9.61e-05	0.00491	CbGeAlD
Norethindrone—ABCB1—lymph node—acquired immunodeficiency syndrome	9.29e-05	0.00475	CbGeAlD
Norethindrone—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.2e-05	0.000708	CcSEcCtD
